Sources | Names Used |
---|---|
CCLE, GRAY | PF-2341066 |
GDSC1000, FIMM | Crizotinib |
gCSI, CTRPv2 | crizotinib |
PharmacoGx | Crizotinib |
Database | Identifier |
---|---|
Smiles: | CC(C1=C(C=C(C=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
Inchikey: | SCJHEFQWKWHQTO-GFCCVEGCSA-N |
Pubchem: | 54613769 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LGALS1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | SLC2A6 | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
mRNA | ZC3HAV1L | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | ENTPD5 | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
mRNA | RUSC1 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.003 |
mRNA | NEK5 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | MKS1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | LYZ | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
mRNA | ASMT | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
mRNA | PARK7 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |